Affinity purification of heparin-dependent antibodies to platelet factor 4 developed in heparin-induced thrombocytopenia: biological characteristics and effects on platelet activation

被引:52
作者
Amiral, J
Pouplard, C
Vissac, AM
Walenga, JM
Jeske, W
Gruel, Y
机构
[1] Hop Trousseau, Lab Hematol Hemostase, F-37044 Tours 1, France
[2] HYPHEN BioMed, F-78570 Andresy, France
[3] Loyola Univ, Med Ctr, Hemostasis Res Labs, Maywood, IL 60153 USA
关键词
heparin-induced thrombocytopenia; antibodies to heparin PF4; platelet activation;
D O I
10.1046/j.1365-2141.2000.02034.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Antibodies to heparin platelet factor 4 (H-PF4) complexes were purified from the plasma of three patients with heparin-induced thrombocytopenia (HIT) using affinity chromatography. From each plasma, the largest amount of antibodies was eluted with 2 M NaCl at pH 7.5 (peak 1) and the remainder was obtained using 0.1 M glycine/0.5 M NaCl at pH 2.5 (peak 2). In an enzyme-linked immunosorbent assay (ELISA), we then showed that each patient had developed antibodies to PF4 displaying different characteristics. In patient 1, peak 1 IgG reacted almost exclusively with H-PF4 complexes, whereas peak 2 IgG had similar reactivity with PF4 whether or not heparin was present, Patient 2 expressed a mixture of IgA, IgM and IgG and both fractions bound to PF4 alone or to H-PF4 complexes. Finally. IgG in patient 3 only bound to H-PF4 and was unreactive with PF4 alone. Using [C-14]-serotonin release assays, the antibodies developed in the three patients and exhibiting the strongest ability to activate platelets with heparin were those having the highest affinity to H-PF4. These results strongly support the hypothesis that HIT antibodies to PF4 are heterogeneous regarding their affinity and specificity for target antigens and this may greatly influence their ability to activate platelets and their pathogenicity.
引用
收藏
页码:336 / 341
页数:6
相关论文
共 21 条
  • [1] AMIRAL J, 1992, THROMB HAEMOSTASIS, V68, P95
  • [2] AMIRAL J, 1995, THROMB HAEMOSTASIS, V73, P21
  • [3] Pathogenicity of IgA and/or IgM antibodies to heparin-PF4 complexes in patients with heparin-induced thrombocytopenia
    Amiral, J
    Wolf, M
    Fischer, AM
    BoyerNeumann, C
    Vissac, AM
    Meyer, D
    [J]. BRITISH JOURNAL OF HAEMATOLOGY, 1996, 92 (04) : 954 - 959
  • [4] Arnout J, 1996, THROMB HAEMOSTASIS, V75, P536
  • [5] Heparin-induced thrombocytopenia:: New insights into the impact of the FcγRIIa-R-H131 polymorphism
    Carlsson, LE
    Santoso, S
    Baurichter, G
    Kroll, H
    Papenberg, S
    Eichler, P
    Westerdaal, NAC
    Kiefel, V
    van de Winkel, JGJ
    Greinacher, A
    [J]. BLOOD, 1998, 92 (05) : 1526 - 1531
  • [6] Activation of platelets by sera containing IgG1 heparin-dependent antibodies: An explanation for the predominance of the Fc gamma RIIa ''low responder'' (his(131)) gene in patients with heparin-induced thrombocytopenia
    Denomme, GA
    Warkentin, TE
    Horsewood, P
    Sheppard, JAI
    Warner, MN
    Kelton, JG
    [J]. JOURNAL OF LABORATORY AND CLINICAL MEDICINE, 1997, 130 (03): : 278 - 284
  • [7] GREINACHER A, 1995, THROMB HAEMOSTASIS, V74, P886
  • [8] GREINACHER A, 1994, THROMB HAEMOSTASIS, V71, P247
  • [9] KELTON JG, 1988, BLOOD, V72, P925
  • [10] KELTON JG, 1994, BLOOD, V83, P3232